MD

Michelle Doig

Partner, Head of Corporate Development at Omega Funds

Toronto, Ontario

Overview

Work Experience

BT

Bicara Therapeutics

  • Board Observer

    2024 - Current

AT

Arrakis Therapeutics

  • Board Observer

    2021

AP

Artios Pharma Ltd

  • Board Member

    2021

OF

Omega Funds

  • Partner, Head of Corporate Development

    2016

Omega Alpha SPAC

  • President and Director

    2020

NB

Nuvation Bio

  • Board Of Directors

    2019 - 2021

TR

Third Rock Ventures

  • Director, Corporate Finance

    2013 - 2016

A

Abingworth

  • Principal, Corporate Finance

    2004 - 2013

LB

Lehman Brothers

  • Associate

    2001 - 2002

Education

Relevant Websites